OHIM to crack down on non-payers

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

OHIM to crack down on non-payers

ohim-logo-45.gif

Two changes affecting CTM applicants will come into effect on November 24: OHIM will only examine applications after they have been paid for, and it will also introduce a fast-track procedure

OHIM logo

The first change is driven by the desire to improve efficiency, as the Office will not spend time examining or processing mail for applications where no payment has been made.

At present, CTM applicants can pay the basic fee within one month of filing the application. About 4% of CTM applications are examined but never paid for, and OHIM says that proportion is rising.

The second change means that applications will be published in half the time it takes regular applications, or even less.

To be eligible for the fast track procedure, applicants must (1) select the goods and services from OHIM’s harmonised database and (2) pay at the end of the application process or immediately after submission. Additionally, the application should not trigger any deficiency finding at the time of submission or during examination.

More details are available on OHIM’s website.



more from across site and SHARED ros bottom lb

More from across our site

Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Gift this article